The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholdings

10 Dec 2020 18:11

RNS Number : 3007I
LiDCO Group Plc
10 December 2020
 

 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Director / PDMR Shareholdings

 

LiDCO (AIM: LID), a leading supplier of hemodynamic monitoring solutions, makes the following announcement in respect of certain dealings in the Company's shares carried out by certain directors on 8 December 2020.

 

Exercise of certain share options

 

On 8 December 2020, the Company announced that the recommended cash offer made by Masimo LHC Limited ("Masimo") for the entire issued and to be issued share capital of LiDCO (the "Offer") had become unconditional in all respects. On the Offer becoming unconditional in all respects, certain Enterprise Management Incentive options ("EMI Options") granted under the Company's Share Option Plan over ordinary shares of 0.5 pence in the capital of the Company ("Shares") became exercisable, to the extent vested at such date.

 

The following directors have each submitted exercise instructions to the Company in respect of the EMI Options shown against their name below, and the relevant number of Shares have been issued and allotted to them in connection with such exercise:

 

Name of PDMR

Date of grant

Date of exercise

Exercise priceper Share

Resulting number of Shares

Matt Sassone

11 April 2017

8 December 2020

0.5 pence

2,200,000

Tim Hall

9 April 2019

8 December 2020

0.5 pence

2,000,000

29 April 2020

8 December 2020

0.5 pence

1,000,000

29 April 2020

8 December 2020

0.5 pence

787,500

 

EMI Options were exercised by other members of staff resulting in a further 3,568,533 Shares being issued and allotted. Admission of the 9,556,033 Shares arising from the exercise of EMI Options has been satisfied via the Company's block listing, application for which was announced on 26 November 2020.

 

The Shares arising from the exercise of EMI Options were issued on 10 December 2020 and immediately following their issue, the directors and other members of staff each sold all of their Shares to Masimo in accordance with their irrevocable commitments to do so in connection with the Offer.

 

Cash cancellation of certain share options

On the Offer becoming unconditional in all respects, certain non-tax-qualifying options ("Non-Qualifying Options") granted under the Company's Share Option Plan over Shares became exercisable, to the extent vested at such date.

 

Matt Sassone has agreed with Masimo to surrender the Non-Qualifying Options shown in the table below, in return for a cash cancellation payment made to him by Masimo of the "see-through value" of the Non-Qualifying Options (i.e. the aggregate value of the resulting Shares that he could have received by exercising his Non-Qualifying Options and selling them at the Offer price, less the aggregate cost of such exercise (being 0.5 pence per Share)):

 

Name of PDMR

Date of grant

Date of cash cancellation

Number of shares under Non-Qualifying Option

"See-through value" of Non-Qualifying Option

Matt Sassone

20 April 2018

8 December 2020

919,250

£105,713.75

9 April 2019

8 December 2020

2,000,000

£230,000.00

 

Non-Qualifying Options held by other members of staff over 2,365,038 shares were also surrendered in return for cash cancellation payments from Masimo with a total "see-through value" of £153,748.

 

Total voting rights and Rule 2.9 update

Following the exercise of EMI Options described above, the Company will have 253,730,941 Shares in issue, each carrying one voting right. There are no shares held in Treasury. The total number of voting rights in LiDCO is therefore 253,730,941. This number may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change in their interest in, LiDCO under the Disclosure and Transparency Rules or under Rule 8 of the Takeover Code.

 

Following the exercise of EMI Options and the cash cancellation of certain Non-Qualifying Options as described above, there are no other in-the-money options over Shares which are capable of exercise.

 

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 ("MAR"). Additional MAR disclosures regarding PDMR dealings are included below.

 

For further information:

 

LiDCO

Peter Grant (Non-Executive Chairman)

Matt Sassone (Chief Executive Officer)

Tim Hall (Chief Financial Officer)

 

Tel: +44 20 7749 1500

Smith Square Partners - Financial Adviser to LiDCO

John Craven

Matt Alexander

 

Tel: +44 20 3696 7260

 

N+1 Singer - Nominated Adviser and Broker to LiDCO

Aubrey Powell

George Tzimas

Tel: +44 20 7496 3600

 

 

 

 

 

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in one percent or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.  An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s).  An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm  (London time) on the 10th Business Day following the commencement of the Offer Period and, if appropriate, by no later than 3.30 pm  (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified.  Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in one percent or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror.  A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8.  A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm  (London time) on the Business Day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Matt Sassone

 

2.

Reason for the notification

a)

Position/status

Chief Executive Officer

 

b)

Initial notification/ Amendment

 

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

LiDCO Group Plc

 

b)

LEI

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Exercise of Enterprise Management Incentive option granted on 11 April 2017 over 2,200,000 Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£11,000

2,200,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Sale of 2,200,000 Shares resulting from the exercise of an Enterprise Management Incentive Option 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£264,000

2,200,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

10 December 2020

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

(1) Cash cancellation of a non-qualifying option granted on 20 April 2018 over 919,250 Shares

(2) Cash cancellation of a non-qualifying option granted on 9 April 2019 over 2,000,000 Shares

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£105,713.75

919,250

£230,000.00

2,000,000

 

d)

Aggregated information

 

Aggregated volume

Price

 

Price(s)

Volume(s)

£335,713.75

2,919,250

 

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Tim Hall

 

2.

Reason for the notification

a)

Position/status

Chief Financial Officer

 

b)

Initial notification/ Amendment

 

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

LiDCO Group Plc

 

b)

LEI

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

(1) Exercise of an Enterprise Management Incentive option granted on 9 April 2019 over 2,000,000 Shares

(2) Exercise of an Enterprise Management Incentive option granted on 29 April 2020 over 1,000,000 Shares 

(3) Exercise of an Enterprise Management Incentive option granted on 29 April 2020 over 787,500 Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£10,000.00

2,000,000

£5,000.00

1,000,000

£3,937.50

787,500

 

d)

Aggregated information

 

Aggregated volume

Price

 

Price(s)

Volume(s)

£18,937.50

3,787,500

 

e)

Date of the transaction

8 December 2020

f)

Place of the transaction

Outside a trading venue

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.005 each ("Shares")

 

 

 

Identification code

ISIN: GB0030546849

b)

Nature of the transaction

Sale of Shares resulting from the exercise of an Enterprise Management Incentive Option 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£454,500.00

3,787,500

 

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

10 December 2020

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKKBKFBDDFBD
Date   Source Headline
1st May 20147:00 amRNSPositive haemodynamic monitoring study
29th Apr 20147:00 amRNSFinal Results
7th Apr 20147:00 amRNSNotice of Results and Investor briefing
17th Mar 20147:00 amRNSLaunch of New Version of LiDCOrapid software
12th Mar 20147:00 amRNSResults of cost effectiveness trial
28th Feb 201411:34 amRNSTotal Voting Rights
12th Feb 20147:00 amRNSTrading update and notice of results
7th Feb 20149:21 amRNSHolding(s) in Company
28th Jan 20143:01 pmRNSHolding(s) in Company
27th Jan 20144:10 pmRNSBlocklisting Application
20th Jan 20149:54 amRNSReplacement:Anaesthetists guidelines supports LID
20th Jan 20147:00 amRNSAnaesthetists guidelines supports LiDCO
18th Oct 20134:04 pmRNSExercise of Share Options
1st Oct 20137:00 amRNSHalf Yearly Report
26th Sep 20137:00 amRNSNotice of Patent Acceptance
20th Sep 20137:00 amRNSInvestor Results Briefing
6th Sep 20134:33 pmRNSHolding(s) in Company
4th Sep 20137:00 amRNSFDA clearance
20th Aug 20137:00 amRNSTrading update
13th Aug 201312:11 pmRNSNotification of major interest in shares
12th Jun 201311:43 amRNSResults of Annual General Meeting
12th Jun 20137:00 amRNSAGM Statement
10th Jun 201310:08 amRNSNotification of major interest in shares
5th Jun 20137:00 amRNSLiDCOrapid in successful recovery programme
31st May 20139:50 amRNSGrant of Share Options
17th May 20133:30 pmRNSNotice of AGM and posting of Annual Report
9th May 20137:00 amRNSLiDCOrapidv2 incorporated in NHS Foundation Trust
8th May 20133:51 pmRNSExercise of Share Options
23rd Apr 20137:00 amRNSPreliminary Results
26th Mar 20137:00 amRNSUS FDA clears for sale LiDCOrapidv2
15th Mar 20137:00 amRNSGrant of LiDCOrapid user interface patent in Japan
22nd Feb 20133:25 pmRNSDirector/PDMR Shareholding
21st Feb 201312:45 pmRNSExercise of Share Options
7th Feb 20137:03 amRNSLaunch and first sales of the LiDCOrapid v2
5th Feb 20137:00 amRNSTrading Update and Notice of Preliminary Results
17th Dec 20127:00 amRNSTrading Statement
29th Nov 20122:00 pmRNSTR-1 Notification of Major Interest in Shares
27th Nov 20127:00 amRNSExercise of Share Options
27th Nov 20127:00 amRNSProtocol using LiDCOrapid improves outcomes
23rd Nov 20127:00 amRNSLiDCOrapid v2 satisfies NICE recommendation
13th Nov 20127:00 amRNSFundraising to raise £2.35 million
23rd Oct 20127:00 amRNSInterim Results
15th Oct 20123:00 pmRNSExercise of Share Options
15th Oct 20127:00 amRNSPremier of LiDCOrapid v2 with Unity Software
14th Sep 20123:20 pmRNSNotice of Interim Results
3rd Sep 201212:00 pmRNSExercise of Share Options
23rd Aug 20127:00 amRNSTrading update and resignation of Director
3rd Aug 20127:00 amRNSNihon Kohden appointed as distributor in Japan
11th Jul 20127:00 amRNSReimbursement approval received in Japan
4th Jul 20123:05 pmRNSGrant of Share Option

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.